Venus Concept announced that it has clearance from the Therapeutic Goods Administration, TGA, in Australia to market the Venus Bliss MAX system. The Venus Bliss MAX is the Company’s flagship platform that offers a comprehensive, world-class solution for all customers’ body treatment needs and is currently available in select markets globally. “We are excited to introduce to the Australian market the Venus Bliss MAX, our device that offers aesthetic clinicians an all-in-one body solution to customers,” said Dr. Hemanth Varghese, President and Chief Operating Officer of Venus Concept. “The Venus Bliss Max continues to receive strong positive feedback globally from service providers of its complete body offering, and we are confident the same success will be replicated in Australia.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VERO:
- Venus Concept Announces Australian Regulatory Approval for Venus Bliss MAX
- Venus Concept sees Q3 revenue at least $17M, consensus $17.83M
- Venus Concept reports Q2 EPS ($3.05) vs ($1.35) last year
- Venus Concept Announces Regulatory Approval for Venus Bliss MAX in Canada
- Venus Concept announces regulatory approval for Venus Bliss MAX